Literature DB >> 28735345

Large facial lymphatic malformation treatment using sclerosing agent followed by surgical resection: clinical and pathology report.

Amir Laviv1, Alexander Maly2, Jawad Abu-Tair3.   

Abstract

Lymphatic malformations are rare slow-flow vascular malformations, with high tendency to appear in the head and neck region. The treatment of these lesions ranges from follow-up to sclerosing agent injection to surgical excision. The authors present a case of a new born with large extensive lingual and submandibular lymphatic malformation, for which the patient underwent tracheostomy and gastrostomy insertion. He was then treated successfully with sclerosing agent injections followed by surgical excision, with 7 years follow-up. The second case presented is a two and a half baby with large lingual lymphatic malformation, treated successfully with doxycycline injections followed by intraoral excision of the lesion. Pathology of the excised lesion is then demonstrated, which shows for the first time the different layers affected by the sclerosing agent.

Entities:  

Keywords:  Doxycycline; Lymphatic malformation; Sclerotherapy; Vascular malformations

Mesh:

Substances:

Year:  2017        PMID: 28735345     DOI: 10.1007/s10006-017-0640-3

Source DB:  PubMed          Journal:  Oral Maxillofac Surg        ISSN: 1865-1550


  13 in total

1.  Percutaneous sclerotherapy in neonatal and infant head and neck lymphatic malformations: a single center experience.

Authors:  Anne Marie Cahill; Els Nijs; Deddeh Ballah; Deborah Rabinowitz; Lynn Thompson; Natalie Rintoul; Holly Hedrick; Ian Jacobs; David Low
Journal:  J Pediatr Surg       Date:  2011-11       Impact factor: 2.545

2.  Successful Treatment of Macroglossia Due to Lymphatic Malformation With Sirolimus.

Authors:  Sule Yesil; Ceyhun Bozkurt; Hikmet Gülsah Tanyildiz; Sibel Akpinar Tekgunduz; Mehmet Onur Candir; Sule Toprak; Gurses Sahin
Journal:  Ann Otol Rhinol Laryngol       Date:  2015-04-22       Impact factor: 1.547

3.  Management of the low-flow head and neck vascular malformations in children: the sclerotherapy protocol.

Authors:  Michael Leung; Ling Leung; Dickson Fung; Wai-lun Poon; Clarence Liu; Kenneth Chung; Paula Tang; Sunny Tse; Tsz-wo Fan; Nicholas Chao; Kelvin Liu
Journal:  Eur J Pediatr Surg       Date:  2013-09-05       Impact factor: 2.191

Review 4.  Doxycycline sclerotherapy in children with head and neck lymphatic malformations.

Authors:  Jeffrey Cheng
Journal:  J Pediatr Surg       Date:  2015-09-04       Impact factor: 2.545

Review 5.  Treatment guidelines of lymphatic malformations of the head and neck.

Authors:  Qin Zhou; Jia Wei Zheng; Hua Ming Mai; Quan Feng Luo; Xin Dong Fan; Li Xin Su; Yan An Wang; Zhong Ping Qin
Journal:  Oral Oncol       Date:  2011-09-08       Impact factor: 5.337

Review 6.  Head and neck lymphatic malformation treatment: a systematic review.

Authors:  Mary Theresa Adams; Babette Saltzman; Jonathan A Perkins
Journal:  Otolaryngol Head Neck Surg       Date:  2012-07-11       Impact factor: 3.497

Review 7.  Lymphatic malformations: review of current treatment.

Authors:  Jonathan A Perkins; Scott C Manning; Richard M Tempero; Michael J Cunningham; Joseph L Edmonds; Fredric A Hoffer; Mark A Egbert
Journal:  Otolaryngol Head Neck Surg       Date:  2010-06       Impact factor: 3.497

8.  Definitive percutaneous treatment of lymphatic malformations of the trunk and extremities.

Authors:  William E Shiels; Brian D Kenney; Donna A Caniano; Gail E Besner
Journal:  J Pediatr Surg       Date:  2008-01       Impact factor: 2.545

Review 9.  Neurointerventional management of low-flow vascular malformations of the head and neck.

Authors:  David J Choi; Ahmad I Alomari; Gulraiz Chaudry; Darren B Orbach
Journal:  Neuroimaging Clin N Am       Date:  2009-05       Impact factor: 2.264

10.  Congenital vascular lesions: clinical application of a new classification.

Authors:  M C Finn; J Glowacki; J B Mulliken
Journal:  J Pediatr Surg       Date:  1983-12       Impact factor: 2.545

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.